Chapman University

Chapman University Digital Commons
Pharmacy Faculty Articles and Research

School of Pharmacy

12-18-2007

Common and Distinct Mechanisms of Different
Redox-Active Carcinogens Involved in the
Transformation of Mouse JB6P+ Cells
Sun Yang
Chapman University, syang@chapman.edu

Bobbye J. Misner
University of California, Irvine

Rita Chiu
University of California, Irvine

Frank L. Meyskens Jr.
University of California, Irvine

Follow this and additional works at: http://digitalcommons.chapman.edu/pharmacy_articles
Part of the Amino Acids, Peptides, and Proteins Commons, Organic Chemicals Commons,
Other Chemicals and Drugs Commons, and the Pharmaceutical Preparations Commons
Recommended Citation
Yang S, Misner B, Chiu R, Meyskens FL. Common and Distinct Mechanisms of Different Redox-active Carcinogens Involved in
transformation of mouse JB6P+ cells. Mol Carcinog. 2008;47(7):485-491. doi: 10.1002/mc.20410

This Article is brought to you for free and open access by the School of Pharmacy at Chapman University Digital Commons. It has been accepted for
inclusion in Pharmacy Faculty Articles and Research by an authorized administrator of Chapman University Digital Commons. For more information,
please contact laughtin@chapman.edu.

Common and Distinct Mechanisms of Different Redox-Active
Carcinogens Involved in the Transformation of Mouse JB6P+ Cells
Comments

This is the accepted version of the following article:
Yang S, Misner B, Chiu R, Meyskens FL. Common and Distinct Mechanisms of Different Redox-active
Carcinogens Involved in transformation of mouse JB6P+ cells. Mol Carcinog. 2008;47(7):485-491. doi:
10.1002/mc.20410
which has been published in final form at DOI: 10.1002/mc.20410. This article may be used for noncommercial purposes in accordance with Wiley Terms and Conditions for Self-Archiving.
Copyright

Wiley

This article is available at Chapman University Digital Commons: http://digitalcommons.chapman.edu/pharmacy_articles/467

HHS Public Access
Author manuscript
Author Manuscript

Mol Carcinog. Author manuscript; available in PMC 2015 September 29.
Published in final edited form as:
Mol Carcinog. 2008 July ; 47(7): 485–491. doi:10.1002/mc.20410.

Common and Distinct Mechanisms of Different Redox-Active
Carcinogens Involved in the Transformation of Mouse JB6P+
Cells
Sun Yang1,2, Bobbye Misner1, Rita Chiu1, and Frank L. Meyskens Jr1,2,3,*,†
1Chao

Family Comprehensive Cancer Center, University of California, Irvine, Orange, California

Author Manuscript

2Department

of Medicine, University of California, Irvine, Orange, California

3Department

of Biological Chemistry, University of California, Irvine, Orange, California

Abstract
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We transformed JB6P+ cells with prolonged intermittent low-dose UVB radiation or prolonged
exposure to low-dose H2O2 or CdCl2. Stable transformation was confirmed by an anchorageindependence assay. The JB6P+ transformants formed more colonies (∼six folds) in soft agar as
compared to their JB6P+ parent cells and were associated with increased intracellular reactive
oxygen species (ROS) levels. Activating protein-1 (AP-1) is a family of transcription factors that
are rapidly activated by elevated intracellular ROS levels, and their composition is important in
the process of cellular transformation and/or tumor progression. To investigate if carcinogenesis
induced by distinct carcinogens was via similar molecular mechanisms in these transformants, gel
mobility shift and immunoblot analyses were utilized to determine the distinct AP-1 compositions.
Compared to parent JB6P+ cells, the gain of JunB and Fra-1 in AP-1 DNA binding complexes was
markedly increased in all transformed cells, which might contribute to a more proliferative
phenotype, while loss of Fra-2 occurred in JB6P+/H2O2 and JB6P+/Cd cells. Differential AP-1
components in the transformants suggested that their transformations might be mediated by
distinct transcription signalings with distinct AP-1 dimer compositions. However, all three
transformants exhibited increased activation of pathways involved in cell proliferation (ERK/
Fra-1/AP-1 and JNK/c-jun/AP-1) and anti-apoptosis (Bcl-xl). The development of the JB6P+
transformants (JB6P+/UVB; JB6P+/H2O2; JB6P+/Cd) provides a unique tool to study the
mechanisms that contribute to different redox-active carcinogens in a single model.
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Introduction
The JB6 mouse epidermal cell lines were first established in the early 1980s by Nancy
Colburn's group and consist of tumor promotion sensitive JB6P+ and tumor promotion
resistant JB6P− cells. These cell lines have been widely utilized as a model of cellular
malignant transformation to study mechanisms that underlie tumor promotion [1–3]. In the
presence of the tumor promoters, JB6P+ cells undergo a response similar to second stage
tumor promotion that is associated with anchorage-independent growth and tumorigenic
transformation; these changes do not occur in JB6P− cells.

Author Manuscript

A growing body of evidence has shown that reactive oxygen species (ROS) at low
concentration act as second messengers in intracellular signaling cascades, which induces
and maintains the oncogenic phenotype of cancer cells; on the other hand, ROS at high
concentrations produce cellular toxicity. This is a common phenomenon in cancer cells,
resulting in redox imbalance and chronic oxidative stresses [4]. Many studies have
demonstrated that the JB6P+ cells are sensitive to cellular transformation by various types of
ROS [5–7].
Ultraviolet light (UV) radiation initiates carcinogenesis by direct DNA damage and
generates ROS that act as second messengers responsible for the alteration of gene
expressions [8,9]. As H2O2 crosses biomembranes freely [10], the exposure of cells to H2O2
is a classical model of direct oxidative stress that not only results in lipid, protein, and DNA
damage, but also acts as a second messenger in promoting tumor survival [11–12].
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Cadmium is a well-studied carcinogenic metal, which is related to air and water pollution
and cigarette smoking [13]. Although cadmium itself is not a transition-state metal (it cannot
generate ROS directly), it is well documented that its carcinogenicity is mediated by the
indirect production of various radicals such as the superoxide radical, hydroxyl radical, and
nitric oxide [13,14], which contribute to the activation of JNK/AP-1 signal transduction
pathways responsible for the transcription of genes involved in cell growth, as seen, for
example, in hepatic cells [15,16].

Author Manuscript

In this study, we transformed the JB6P+ cells with low-dose intermittent UVB radiation or
continuous exposure to low-doses of H2O2 or cadmium chloride (JB6P+/UVB, JB6P
+/H2O2, JB6P+/Cd), events which are all mediated by ROS production. The comparisons of
subsequent alterations of transcription factors (i.e., activating protein-1, AP-1) or
proliferation signalings that are sensitive to oxidative stresses are the major focus of this
current study. The development of these new transformants has provided a unique
opportunity to study the mechanisms that underlie carcinogenesis in a single model with
different redox-active stimuli.

Materials and Methods
JB6P+ Cell Transformation
The JB6P− and the JB6P+ cells were obtained from ATCC (Manassas, Virginia). The JB6P
+ cells were seeded at low density (1.5 × 104 cells/mL) in 60 mm dishes. UVB (10 mJ/cm2)
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treatments were performed twice a week, 24 h after the cells were re-seeded. JB6P+ cells
were incubated with growth media containing H2O2 (10 µM) or CdCl2 (1 µg/mL) for 12 wks
and the media were changed at least twice a week. The control JB6P+ cells were treated
with the same volume of sterile H2O at the same time. The cells were allowed to grow to a
60% confluence before splitting. All of the cells were cultured in EMEM medium
supplemented with 4% bovine fetal serum, L-glutamine (2 mM), and 25 µg/mL gentamicin
then incubated with 5% CO2 at 37°C. After 12 wks, cell transformations were confirmed by
the anchorage-independent growth assay.
Anchorage-Independent Cell Transformation Assay
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Cell transformation in the presence or absence of TPA was investigated by soft agar colony
formation analysis. Cells (8 × 103/mL) were exposed to TPA (10 or 20 ng/mL) in 1 mL of
0.33% basal medium Eagle agar containing 10% FBS. The cultures were incubated in a 5%
CO2 atmosphere at 37°C for 14–18 d [2] and the colonies (containing >50 cells) were
quantified using a light microscope at 40× magnification.
Protein Extraction and Western Blot Immunoassay
Nuclear extracts from JB6P cells were prepared as described previously with minor changes
[17]. Whole cell lysis extracts were prepared according to the directions of the manufacturer
(Cell Signaling Technology, Danvers, MA). Using a Bio-Rad Dc protein assay kit (Bio-Rad
Laboratories, Hercules, CA), protein concentrations of all the samples were precisely
measured to confirm equivalent loading. Immunoblot analysis was performed as previously
described [17]. Specifically, equal amounts of nuclear protein (20–25 µg) or whole cell
protein (50–100 µg) were loaded respectively per sample.

Author Manuscript

Electrophoretic Mobility Shift Assay (EMSA) of AP-1 and NF-κB DNA-Binding Activity
AP-1 binding activities were determined by Gel Shift Assay Systems (Promega, Madison,
WI) with optimizations. Briefly, nuclear extract was incubated in a final volume of 10 μL
containing 2 µL gel shift binding buffer (5×), 1 µL 32P-labeled AP-1 consensus oligos
(approx., 6 × 105 cpm). Two microliters of antibodies to AP-1 members (Santa Cruz
Biotechnology®, Inc., Santa Cruz, CA) was added to reaction mixtures for supershift. For
oligonucleotide competition experiments, each reaction was preincubated with a 50-fold
excess unlabeled AP-1 for 20 min before the addition of hot probes. The mixtures were
separated on 4–5% nondenaturing polyacrylamide gels. Using autoradiography the shift
bands were quantitated by densitometry.

Results and Discussion
Author Manuscript

JB6 cell lines are a unique model to study the molecular events and mechanisms involved in
tumor promotion. The exposure of JB6P+ cells to TPA, EGF, or TNF-α leads to irreversible
transformation and tumorigenicity with acquired anchorage independent growth. Many
studies have demonstrated that early events induced by ROS stresses, such as activation of
AP-1or NF-κB pathways, play an important role in the transformation of JB6 P+ cells [18].
It is well documented that UVB radiation, H2O2, or CdCl2 either directly or indirectly lead
to elevated ROS stresses [9]. In addition, our data consistently showed that in JB6P+ cells a
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one-time exposure of UVB (40 mJ/cm2) radiation led to a significant increase of ROS
production in JB6P+ cells compared to that of the control [19] and that the elevation of ROS
was measurable for at least 24 h. A similar increase in DCF density was also observed with
CdCl2 treatment. The peak occurred shortly after 5 min of exposure, followed by a quick
reduction to normal levels by 30 min. An anchorage-independent cell growth assay was
performed to determine if cellular transformation had occurred by chronic repeated exposure
of UVB or persistent H2O2 or Cd exposure. The JB6P− cells did not form colonies in soft
agar either in the presence or absence of the tumor promoter TPA. However, a small amount
of JB6P+ colonies were evident, and were remarkably increased by TPA stimulation. For all
of the transformants, in the absence of TPA, colonies formed at a frequency of 5–10-folds
that of unstimulated JB6P+ parent cells and 1–2-folds that of TPA-stimulated ones [19].
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Based on these observations, we propose that although the malignant transformations were
induced by distinct types of carcinogens (UVB, Cd, or H2O2), their effects are all mediated
by elevated ROS production. As many cell signalings are very sensitive to oxidative
stresses, we further delineated whether these transformations were preceded through the
regulation of similar or different downstream targets. Specifically, AP-1 is a family of
transcription factors that are rapidly activated by elevated intracellular ROS levels [9,20].
The AP-1 comprises a large family of basic-region leucine zipper (bZIP) transcription
factors (including c-jun, JunB, JunD, c-Fos, FosB, Fra-1, and Fra-2) and forms distinct
heterodimers or homodimers, which differentially regulate downstream target genes. The
dynamic changes in Jun and Fos compositions depend on the initiating stresses, which play a
key role in defining whether cells undergo apoptosis, survival, or senescence through
subsequent downstream shift of the signaling pathways (for recent reviews see References
[21,22]). Therefore, it is important to evaluate the AP-1 components in different JB6 cells.
In our current study, we therefore, utilized gel mobility supershift and Western blot assays to
identify the distinct compositions of AP-1 complexes among JB6P− cells, JB6P+ cells, and
the new transformants.

Author Manuscript

Nuclear extracts, prepared from different JB6 cells, were incubated with 32P-AP-1 in the
presence of antibodies to detect specific AP-1 member proteins. As shown in Figure 1A,
additions of anti-JunD and anti-Fra-2 antibodies resulted in a strong supershift of AP-1
bands, indicating the presence of JunD and Fra-2 in the AP-1 DNA binding complexes in
JB6P− cells. Similar supershifts were also observed in other JB6 cells (as shown in Figure
1B–E) and the results were summarized in Table 1. Our EMSA analysis revealed a
remarkable gain of JunB and Fra-1 in all the transformants compared to their parent JB6P+
cells. Fra-2 was observed in JB6P+ and JB6P+/UVB cells but absent in JB6P+/H2O2 and
JB6P+/Cd extracts. In contrast to promoter resistant JB6P− cells, c-jun antibody produced a
retarded AP-1 band in JB6P+ cells as well as in all the transformants extracts. However,
compared to c-jun, antibodies to JunB, JunD, and Fra-1 produced more pronounced supershift bands, indicating that they might be the major constituents in AP-1 complexes. JunD
was detected in all JB6P cells, while c-Fos and FosB were absent in all of these cells.
Induction of Fra-1 expression was shown in all of our transformants and JB6P+ cells
compared to JB6P− by immunoblotting assay (Figure 2A), while supershifts of AP-1 DNA
binding by Fra-1 antibody only occurred in transformed cells (Figure 1), indicating the
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involvement of Fra-1 in AP-1 complexes. Different from c-Fos, the prototype of the Fos
family, Fra-1 alone does not exhibit any transformation activity [21,23]; However, Fra-1
does contribute to tumor progression through distinct mechanisms and many of its
downstream target genes are involved in cell survival, proliferation, and invasiveness [24].
Elevated Fra-1 expression has been reported in many cancer cells and has been suggested to
serve as an important target for cancer prevention or intervention [25].
EMSA revealed that JunB binding occurred in all of our transformed JB6P+ cells. Although
there are studies showing that JunB exhibits anti-oncogenic activities and acts as an
antagonist of c-jun both in vitro and in vivo [21,22,26,27], elevated JunB expression levels
have been detected in many human tumors such as lymphomas and breast cancer cells,
which correspond to cell cycle promoter cyclin D1 [28–30]. This dramatic increase of JunB
in AP-1 complexes suggests a possible common role of JunB in transformation.
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Fra-2 has been described as a less potent trans-activator than c-Fos with a weak
transforming efficacy [31]. Recent studies using a knock-out mice model have showed that
Fra-2 is required for postnatal survival [32], and in breast cancer cells overexpression of
Fra-2 was associated with a more aggressive tumor phenotype [33]. Dimerization with c-jun,
Fra-2 rescued cells from experimentally induced growth arrest [34]. On the other hand,
studies have also suggested a role of Fra-2 in cellular differentiation in ovarian granulose,
osteoblasts, muscle, and melanoma [35]. The loss of Fra-2 in AP-1 complexes in H2O2- and
CdCl2-transformed JB6P+ cells might contribute to the development to fa proliferative
phenotype.
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Interestingly, our immunoblot results were not correlated to the EMSA findings. The
inductions of c-Fos that occurred in all of the transformants as measured by immunoblotting
were consistent with the finding of studies in other tumor cells [30,36]. Notably, the JB6P
+/UVB transformant exhibited a similar pattern of elevated phos-c-jun, JunB, and c-Fos as
reported with one single dose of UVB radiation, which was because of the MAPKs
pathways (ERK, JNK, and p38) activated by UVB-generated ROS [37–39]. However, we
failed to observe any c-Fos-specific shifted bands by EMSA. A similar inconsistency was
seen with Fra-1 in JB6P+ cells. In contrast to immunoblotting, the EMSA gel shift assay
mimics AP-1 DNA bindings in vitro and identifies DNA-bound proteins using specific
antibodies in a nondenaturing condition.
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We further explored the distinct gene expressions associated with proliferation and apoptosis
among these cells. The role of MAPK signaling in proliferation is well characterized [40].
As shown in Table 2 and Figure 2B, our study revealed increases of phosphorylated ERK
and JNK in all the transformants (JB6P+/UVB, 1.5- and 1.9-fold; JB6P+/ H2O2, 2.2- and
1.5-fold; JB6P+/Cd, 1.9- and 1.5-fold respectively) as compared to JB6P+ cells (1.2- and
0.9-fold respectively, levels in JB6P− standardized as 1.0). These findings coincided and
supported other observations, which have suggested the critical involvement of MAPK in
tumor promotion and carcinogenesis [18,41,42]. Notably, no significant alterations of p38
activities were observed (data not shown); these results are in contrast to the reports
indicating the involvement of p38 after UV exposure [43,44]. The explanation might be
related to the differential UV exposure among studies.
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Fra-1 is regulated at both transcriptional and posttranscriptional levels. Characterized as an
immediate early response gene, Fra-1 is activated by the MAPK and PI3K/AKT pathways.
Additionally, ERK plays a critical role in the stabilization of Fra-1 protein upon
phosphorylation to prevent degradation by the proteasome [45,46]. Overexpression of Fra-1
was found in many cancer cells displaying high ERK activities [47] and TPA-induced Fra-1
activities were ERK-dependent [48]. Therefore, the level of activated ERK is very important
for regulating Fra-1/AP-1 activities. The remarkable activations of ERK in transformants
identified by our study might be closely related to the enhanced Fra-1 activities.
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Phosphorylated JNK is the active form of JNK, which subsequently phosphorylates c-jun
and leads to an increase of its DNA binding activities. Increased ratios of phosphorylated
JNK/JNK were seen in all the transformants (Table 2). Consistently, phosphorylated c-jun
was also found elevated in the transformants (Table 2, Figure 2B), which contributed to a
significant increase of AP-1 transcriptional activities evident in transformants compared to
the parent cells [19]. c-jun has been shown to perform an important function in the
proliferation of cancer cells [21]. The critical role of the activation of AP-1 transcription
factors in carcinogenesis was recently detailed [18] and for this reason, the JB6 model is
unique in defining molecular events in the MAPK/ AP-1 and NF-κB pathway that lead to
tumor promotion. No remarkable differences of Cdk2, a well-known protein found
throughout the G phase to the S phase of the cell cycle, were observed among these cell
lines.
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We also examined the expression levels of Bcl-xl and Bax. Bcl-xl was not detected in the
JB6P− cells, but showed a substantial increase in the JB6P+ transformants as compared to
the JB6P+ parent cells. No significant changes in Bax protein levels were observed among
these cell lines. Bcl-xl is a target gene of the NF-κB pathway, which has been implicated
broadly in tumorigenesis. Remarkable activation of NF-κB was evident both in basal and
UVB-treated JB6P+ cells [18,49], as well as in H2O2- and Cd-treated cells [9,50]. This
might lead to the induction of Bcl-xl in order to enhance survival and contribute to the
transformation process. In JB6-derived RT-101 cells, TNF-α-induced apoptosis was because
of a decrease in anti-apoptotic Bcl-xl [51].
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The differential AP-1 protein compositions exhibited in the JB6P+ variants suggest that
these cells were transformed by different mechanisms; however, our data also suggested that
the JNK/c-jun/AP-1 and ERK/Fra-1/AP-1 pathways are being extensively activated in these
JB6P+ variants even though the transformation was induced by distinct carcinogens. Based
on our observations, it is suggested that active MAPKs inhibitors might exhibit potential
chemopreventive activities by blocking the transformation induced by a broad range of
carcinogens.
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AP-1

activator protein-1

AKT

protein kinase B

DCF

2′,7′-dichlorofluorescein

EGF

epidermal growth factor

ERK

extracellular signal-regulated kinase

HE

dihydroethidium

JNK

jun N-terminal kinase

MAPK

mitogen-activated protein (MAP) kinases

NF-κB

nuclear factor kappa B

PI3K

phosphoinositide 3-kinase

ROS

reactive oxygen species

TPA

12-O-tetradecanoyl-phorbol-13-acetate

UVB

ultraviolet light (290–320 nm)
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Figure 1.

EMSA and supershift analysis of AP-1 DNA-binding activities and composition in JB6
cells. EMSA with 32P-labeled AP-1 oligonucleotide probe was performed as described in
“Materials and Methods” and 50× excess unlabeled AP-1 was added for the competition.
The nuclear extracts were subjected to EMSA in the absence or presence of antibodies to the
indicated AP-1 proteins. JB6 cell lines were grown in their EMEM growth medium as
detailed in the “Materials and Methods.” (A–E) JB6P−, JB6P+ cells, JB6P+/UVB, JB6P
+/H2O2, JB6P+/Cd cells respectively.
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Figure 2.

The representative results of AP-1 member protein (A) and related genes (B) expressions
detected by Western immunoblotting analysis. Cells were collected under normal culture
condition and nuclear protein extracts were extracted as described in “Material and
Methods.” Protein expression was determined by Western blotting with antibodies specific
for phospho-c-jun, JunB, JunD, c-Fos, Fra-1, phospho-MAPK, MAPK, Bcl-XL, Bax, actin,
and tubulin respectively. Arrows indicate specific bands.
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▲

▲
▲

▲

▲

▲

JB6P+/H2O2

JB6P+/Cd

c-Fos

FosB

▲

▲

▲

Fra-1

▲

▲

▲

Fra-2

▲ represents the presence of certain AP-1 members in DNA-binding complexes.

▲

▲

▲
▲

▲

▲

JunD

JB6P+/UVB

JunB

JB6P+

JB6P−

c-jun
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1.0
1.0
0.0
1.0
1.0
1.0
1.0
1.0
1.0
1.0
0
1

JNK

Ratio phos. JNK/JNK

Phospho-c-jun

Phospho-ERK

ERK

Ratio phos. ERK/ERK

Phospho-p38 MAPK

p38 MAPK

Ratio phos. p38/p38

Cdk2

Bcl-xl

Bax

1.1

1.0

0.9

0.9

1.4

1.2

2.0

0.6

1.2

1.0

0.7

1.4

0.94

JB6P+

1.0

2.2

1.4

0.8

1.6

1.3

3.0

0.5

1.5

2.3

2.4

0.8

1.9

JB6P+/UVB

1.3

3.4

1.0

0.9

1.8

1.6

4.4

0.5

2.2

2.9

3.0

0.5

1.5

JB6P+/H2O2

1.2

2.1

1.1

0.9

2.0

1.8

6.3

0.3

1.9

1.9

2.1

0.7

1.5

JB6P+/Cd

Densitometric measurements of immnunoblotted proteins were normalized to the JB6P- cells. As Bcl-xl was not detected in the JB6P− cells, this protein was normalized to the JB6P+ results.

1.0

Phospho-JNK

JB6P−

Relative Densitometric Measurements of Basal Levels of Phospho-JNK/JNK, Phospho-ERK/ERK, Phospho-p38/p38 MAPK, Cdk2, Bcl-xl,
and Bax Proteins as Determined by Western Immunoblotting
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